Robert F. Murray, III

Mr. Rob Murray has served as Chief Business Officer of GCAR since 2020, providing leadership on the strategic growth of GCAR and its initiatives.

As Chief Business Officer, Mr. Murray brings extensive clinical and business development expertise to help expand GCAR’s pharma partner model, lead vendor engagement, manage key strategic relationships, and engage with patient advocacy organizations to advance GCAR’s patient-first mission.

Mr. Murray has been committed to clinical research since learning that his mother was diagnosed with multiple sclerosis in the late 1980s. While at the University of North Carolina, Mr. Murray shifted his research interests to inflammation and later, while working in the laboratory of Nobel Laureate, Dr. Oliver Smithies, cancer research became his passion. 

Professionally, Mr. Murray held progressively senior roles while at IQVIA and IQVIA Biotech for over 20 years, where cancer research was the primary focus. During that time, IQVIA Biotech supported the development of 9 FDA approved oncology products.

Prior to his transition to GCAR, Mr. Murray was instrumental in branding strategy, sales and marketing initiatives, and commercial constructs to support the successful launch of IQVIA Biotech.

Mr. Murray holds a Bachelor of Science from The University of North Carolina at Chapel Hill and a Master of Business Administration from the University of Phoenix.